Tidigare pristagare – Former Laureates

The Scheele Award Laureate 2023

Professor Peter G. Schultz’s research, teaching and entrepreneurial efforts have had a major impact on human health, the ability of chemists to synthesize molecules to meet the medical challenges of the future, and the direction of modern chemistry.

Schultz is one of the pioneers in the field of chemical and synthetic biology, introducing unnatural amino acids as an important tool to study biology. His basic science and discoveries have been instrumental in the development of combinatorial chemistry and large-scale phenotypic screening methodologies, fundamental to generating biological data of high relevance.

The techniques pioneered by Schultz have transformed the development of innovative new medicines globally. This is exemplified by recent research from Schultz’s own lab, enabling translation of new classes of drugs that affect endogenous stem cells for the treatment of neurodegenerative diseases.

The Scheele Award Laureate 2021

Professor Craig Crews, Yale University ”for his broad excellence in drug discovery and development, spanning from molecule to patient. He has combined groundbreaking science with strong entrepreneurship and received wide international recognition for his work on pharmacological modulation of protein turnover. His findings have led to new therapeutic approaches including the development of novel proteasome inhibitors and the PROTAC technology.”

The Scheele Award Laureate 2019

Professor Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens, Berlin “for deciphering the molecular mechanisms of the CRISPR/Cas9 system – a gene editing tool with multiple applications in drug discovery and development.” Read more about Professor Charpentier and her research here.

The Scheele Award Laureate 2017

Professor Charles L Sawyers, Memorial Sloan Ketterering Cancer Center NY, USA “for his outstanding contributions in life sciences. Professor Sawyers’ work has provided insights on the molecular mechanisms causing tumour drug resistance which has paved the way to new effective cancer treatments saving the lives of many patients.” Read more about Professor Sawyers and his research here.

The Scheele Award Laureate 2015

Professor Robert S Langer, MIT, USA ““for his extraordinary achievements in Pharmaceutical Sciences. Professor Langer is a pioneer of drug delivery including controlled release- and non-invasive delivery systems across complex barriers in the body. His innovations has led to improved therapies and saved the lives of many patients. In addition Professor Langer is also known as the founder of tissue engineering in regenerative medicine” Read more about Professor Langer and his research here.

Scheele Award Laureates 1961-

Later Nobel Laureates are underlined

2021	Prof Craig Crews ”For his broad excellence in drug discovery and development, spanning from molecule to patient.”	Yale University	USA
2019	Prof Emmanuelle Charpentier ”For deciphering the molecular mechanisms of the CRISPR/Cas9 system – a gene editing tool with multiple applications in drug discovery and development”	Max Planck Unit for the Science of Pathogens	Tyskland
2017	Prof Charles L Sawyers ”For his outstanding contributions in life sciences. Professor Sawyers’ work has provided insights on the molecular mechanisms causing tumour drug resistance which has paved the way to new effective cancer treatments saving the lives of many patients”	Memorial Sloan Ketterereing Cancer Center	USA
2015	Prof Robert S Langer “For his extraordinary achievements in Pharmaceutical Sciences. Professor Langer is a pioneer of drug delivery including controlled release- and non-invasive delivery systems across complex barriers in the body. His innovations has led to improved therapies and saved the lives of many patients. ”	MIT	USA
2013	Prof Garret A FitzGerald	University of Pennsylvania	USA
2011	Prof Kathleen M Giacomini	University of California, San Fransisco	USA
2009	Prof Dennis J Slamon	Universitu of California, Los Angeles	USA
2007	Prof Mathias Uhlén	Royal Institute of Technology	Sweden
2005	Prof Jan van der Greef ”In view of his outstandning and visionary contributions in the field of pharmaceutical and biomedical analysis”	Leiden University	NL
2003	Prof Johathan A Ellman ”in view of his outstandning contributions and pioneering work in the interface between combinatorial and medicinal chemistry”	University of California, Berkley	USA
2001	Prof Andrew H Wyllie ”In view of his outstandning contributions in the field of apoptosis”	University of Cambridge	UK
2000	Prof Douwe D Breimer ”In view of his outstandning contributions in the field of pharmaceutical science at large and pioneer reserach in pharmacokinetics and pharmacodynamics.”	Leiden University	NL
1999	Prof John W Daly ”In view of his outstandning contributions in the field of natural product chemistry at large and his special skills and insights centereda round the concept of bioactive natural products as lead compounds and as pharmacological tools in drug discovery.”	National Institute of Health	USA
1998	Prof Albert I Wertheimer	Merck & Co Inc	USA
1997	Prof Julian E Davies	University of British Columbia	Canada
1996	Prof Gordon L Amidon	University of Michigan	USA
1995	Prof Patrick J Hendra	University of Southampton	UK
1994	Prof Gregory P Winter	Univeristy of Cambridge	UK
1993	Prof Alexander T Florence	University of London	UK
1992	Prof Koji Nakanishi	Suntory Institute	Japan
1991	Prof K Barry Sharpless	Massachusetts Institute of Technology	USA
1990	Prof Gerhard Levy	State University Of New York at Buffalo	USA
1989	Prof Dennis V Parke	University of Surrey	UK
1988	Prof David V Goeddel	Genenteck Inc	USA
1987	Prof Roland W Frei	Free University of Amsterdam	NL
1986	Prof Luc Montagnier	Institute of Pasteur	France
1985	Prof Stanley S Davis	University of Nottingham	UK
1984	Prof Malcolm Rowland	University of Manchester	UK
1983	Sir James W Black	Wellcome Research Labs	UK
1982	Prof Charles Weissmann	University of Zürich	Switzerland
1981	Prof George J Aghajanian	Yale University	USA
1980	Prof Harri R Nevanlinna	Blood Service of the Finnish Red Cross	Finland
1979	Prof Peter Speiser	ETH, Zürich	Switzerland
1978	Prof Sidney Riegelman	University of California	USA
1977	Prof Hans W Kosterlitz	University of Aberdeen	UK
1976	Prof Evan C Horning	Texas Medical Center	USA
1975	Prof Edward P Abraham	Oxford University	UK
1974	Prof E J Ariëns	University of Nijmegen	NL
1973	Prof Harold N MacFarland	Bio Research Lab Ltd	Canada
1972	Prof Carl Djerassi	Stanford University	USA
1971	Dr Albert Hofmann	Sandoz	Switzerland
1970	Dr Norman J Harper	Winthrop Labs	UK
1969	Prof Takeru Higuchi	University of Kansas	USA
1968	Prof Arnold H Beckett	Chelsea College of Science and Technology	UK
1967	Prof Bernard B Brodie	National Institute of Health	USA
1965	Dr Paul Janssen	Janssen Pharmaceutica	Belgium
1964	Dr Lewis H Sarett	Merck Sharp & Dhome	USA
1963	Prof Robert Schwyzer	CIBA	Switzerland
1962	Dr Frank P Doyle	Beecham Research Labs	UK
1961	Dr Frank L Rose	ICI	UK